Company Profile
|
Hisamitsu Pharmaceutical Co. Inc.
(OTC: HTSUY)
|
7:03 PM UTC, 06/28/24 | |||
|---|---|---|---|---|
| Last: $5.44 | Change: -0.77 | %Change: -12.40% | Volume: 1,000 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 5.44 | Volume: | 1,000 | |
|---|---|---|---|---|
| High: | $ 5.44 | Yield(%) | 1.93 | |
| Low: | $ 5.44 | P/E Ratio (ttm): | 18.33 | |
| Dividend ($): | 0.04 | Market Cap ($): | 1.76B | |
| EPS ($) | 0.32 | Shares Out: | 302.97M |
| % Price Change (last 4 weeks): | -5.34 |
|---|---|
| % Price Change (last 13 weeks): | -8.26 |
| % Price Change (last 26 weeks): | -23.46 |
| % Price Change (last 52 weeks): | -12.06 |
| % Price Change (year to date): | -24.00 |
| Return on Equity (%): | 5.34 |
|---|---|
| Return on Assets (%): | 4.33 |
| Return on Invested Capital (%): | 4.93 |
| Gross Profit Margin (%): | 55.73 |
|---|---|
| Net Profit Margin (%): | 9.86 |
| Operating Profit Margin (%): | 9.29 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $n/a |
|---|---|
| 200-day Moving Average: | $n/a |
| Avg. Daily Vol. (last 50 days): | n/a |
| Avg. Daily Vol. (last 200 days): | n/a |
| 52-wk high: | $9.35 |
| 52-wk low: | $5.44 |
| Bid: | $n/a |
| Ask: | $n/a |
|
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
|
|
Hisamitsu Pharmaceutical Co. Inc.
408 Tashiro Daikan-machi Tosu SA 841-0017 Phone: 81.942.83.2101 Fax: n/a http://www.hisamitsu.co.jp |
| Earnings (1year) ($): | 0.32 |
|---|---|
| Annual Dividend ($): | 0.11 |
| Current P/E Ratio (ttm): | 18.33 |
| Book Value ($): | 5.84 |
| Cash Flow ($): | 0.44 |
| Price/Earnings (x): | 18.33 |
|---|---|
| Price/Sales (x): | 2.01 |
| Price/Book (x): | 1.11 |
| Price/Cash Flow (x): | 15.70 |
| Quick Ratio (x): | 3.76 |
|---|---|
| Current Ratio (x): | 4.22 |
| LT Debt/Equity (x): | 0.26 |
| Total Debt/Equity (x): | 0.79 |
